Figure 1From: Safety and efficacy of lumefantrine-artemether (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adultsTrial profile. Legend: † 2 ETF in HIV-1 were serious adverse events. †† Patients facing an event (excluded, lost to follow up or new infection) were censored at the time of the last recorded visit and included in the survival analysis.Back to article page